Concepts (146)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Zika Virus Infection | 6 | 2018 | 8 | 2.770 |
Why?
|
| Guillain-Barre Syndrome | 5 | 2018 | 7 | 2.180 |
Why?
|
| Cerebral Hemorrhage | 7 | 2020 | 140 | 1.640 |
Why?
|
| Nervous System Diseases | 4 | 2020 | 156 | 1.520 |
Why?
|
| Subarachnoid Hemorrhage | 4 | 2022 | 68 | 1.510 |
Why?
|
| Thrombolytic Therapy | 3 | 2016 | 58 | 1.080 |
Why?
|
| Zika Virus | 5 | 2018 | 7 | 1.080 |
Why?
|
| Heart Neoplasms | 2 | 2013 | 15 | 0.840 |
Why?
|
| Myxoma | 2 | 2013 | 9 | 0.840 |
Why?
|
| Encephalitis | 2 | 2023 | 18 | 0.820 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 3 | 2016 | 9 | 0.770 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 12 | 0.730 |
Why?
|
| Brain Death | 1 | 2020 | 17 | 0.730 |
Why?
|
| Occupational Health | 1 | 2020 | 21 | 0.730 |
Why?
|
| Brain Edema | 1 | 2020 | 23 | 0.730 |
Why?
|
| Apnea | 1 | 2020 | 17 | 0.730 |
Why?
|
| Encephalocele | 1 | 2020 | 32 | 0.720 |
Why?
|
| Brain Ischemia | 2 | 2022 | 75 | 0.690 |
Why?
|
| Cerebrovascular Circulation | 2 | 2016 | 43 | 0.680 |
Why?
|
| Hypothermia, Induced | 2 | 2013 | 22 | 0.640 |
Why?
|
| Heart Arrest | 2 | 2013 | 57 | 0.620 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2018 | 27 | 0.610 |
Why?
|
| Critical Care | 4 | 2023 | 246 | 0.600 |
Why?
|
| Humans | 32 | 2023 | 31073 | 0.590 |
Why?
|
| Environmental Pollution | 1 | 2017 | 1 | 0.570 |
Why?
|
| Environmental Illness | 1 | 2017 | 2 | 0.570 |
Why?
|
| Blood Cell Count | 1 | 2016 | 17 | 0.560 |
Why?
|
| Tissue and Organ Procurement | 1 | 2015 | 35 | 0.480 |
Why?
|
| Attitude to Health | 1 | 2015 | 99 | 0.460 |
Why?
|
| Factor VIIa | 1 | 2013 | 9 | 0.440 |
Why?
|
| Vitamin K | 1 | 2013 | 10 | 0.440 |
Why?
|
| Blood Coagulation Factors | 1 | 2013 | 19 | 0.430 |
Why?
|
| Anticoagulants | 2 | 2013 | 110 | 0.430 |
Why?
|
| Pancreatitis | 1 | 2013 | 25 | 0.430 |
Why?
|
| Warfarin | 1 | 2013 | 39 | 0.430 |
Why?
|
| Brazil | 4 | 2023 | 46 | 0.430 |
Why?
|
| Abducens Nerve Diseases | 1 | 2012 | 3 | 0.420 |
Why?
|
| Aneurysm | 1 | 2012 | 12 | 0.420 |
Why?
|
| Central Nervous System Diseases | 1 | 2012 | 23 | 0.410 |
Why?
|
| Thrombosis | 1 | 2013 | 64 | 0.410 |
Why?
|
| Leukocytosis | 3 | 2021 | 9 | 0.400 |
Why?
|
| Neurology | 1 | 2013 | 79 | 0.390 |
Why?
|
| Female | 15 | 2023 | 17017 | 0.370 |
Why?
|
| Middle Aged | 10 | 2023 | 10240 | 0.350 |
Why?
|
| Male | 13 | 2023 | 16499 | 0.340 |
Why?
|
| Internship and Residency | 1 | 2013 | 227 | 0.330 |
Why?
|
| Fever | 2 | 2016 | 42 | 0.320 |
Why?
|
| Incidence | 4 | 2019 | 790 | 0.310 |
Why?
|
| Age Factors | 4 | 2020 | 875 | 0.300 |
Why?
|
| Disease Outbreaks | 2 | 2018 | 93 | 0.300 |
Why?
|
| Hypoxia | 2 | 2020 | 63 | 0.280 |
Why?
|
| Epidemics | 1 | 2016 | 4 | 0.270 |
Why?
|
| Aging | 1 | 2016 | 1729 | 0.270 |
Why?
|
| Fibrinolytic Agents | 1 | 2016 | 63 | 0.270 |
Why?
|
| Adult | 8 | 2023 | 8950 | 0.260 |
Why?
|
| Logistic Models | 3 | 2016 | 411 | 0.250 |
Why?
|
| Telemedicine | 1 | 2016 | 112 | 0.230 |
Why?
|
| Central Nervous System Infections | 1 | 2023 | 6 | 0.230 |
Why?
|
| Brain Abscess | 1 | 2023 | 7 | 0.230 |
Why?
|
| Meningitis | 1 | 2023 | 11 | 0.230 |
Why?
|
| Databases, Factual | 3 | 2020 | 354 | 0.220 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2021 | 105 | 0.220 |
Why?
|
| Cerebral Infarction | 2 | 2022 | 164 | 0.220 |
Why?
|
| Migraine Disorders | 1 | 2013 | 14 | 0.210 |
Why?
|
| Stroke | 1 | 2016 | 315 | 0.210 |
Why?
|
| Vasospasm, Intracranial | 1 | 2022 | 18 | 0.210 |
Why?
|
| Weather | 2 | 2019 | 18 | 0.200 |
Why?
|
| Acute Disease | 3 | 2017 | 232 | 0.200 |
Why?
|
| Risk Factors | 7 | 2021 | 2591 | 0.200 |
Why?
|
| Treatment Outcome | 5 | 2021 | 3810 | 0.190 |
Why?
|
| Odds Ratio | 2 | 2016 | 293 | 0.190 |
Why?
|
| Aged | 7 | 2021 | 10082 | 0.190 |
Why?
|
| Cerebrum | 1 | 2021 | 13 | 0.190 |
Why?
|
| Cerebral Amyloid Angiopathy | 2 | 2019 | 120 | 0.180 |
Why?
|
| Fatal Outcome | 1 | 2020 | 65 | 0.180 |
Why?
|
| Hyperglycemia | 1 | 2020 | 37 | 0.180 |
Why?
|
| Blood Glucose | 1 | 2020 | 120 | 0.170 |
Why?
|
| Cerebral Angiography | 3 | 2022 | 33 | 0.170 |
Why?
|
| Young Adult | 3 | 2017 | 2061 | 0.160 |
Why?
|
| Campylobacter Infections | 1 | 2018 | 11 | 0.160 |
Why?
|
| Retrospective Studies | 6 | 2023 | 3665 | 0.160 |
Why?
|
| Prognosis | 4 | 2020 | 924 | 0.160 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 428 | 0.160 |
Why?
|
| Neuritis | 1 | 2017 | 2 | 0.150 |
Why?
|
| Electromyography | 1 | 2017 | 78 | 0.150 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2017 | 131 | 0.140 |
Why?
|
| Neuroimaging | 1 | 2018 | 144 | 0.140 |
Why?
|
| Hypothermia | 1 | 2017 | 7 | 0.140 |
Why?
|
| Ohio | 1 | 2016 | 9 | 0.140 |
Why?
|
| Pregnancy | 1 | 2018 | 404 | 0.140 |
Why?
|
| Intracranial Aneurysm | 1 | 2016 | 34 | 0.140 |
Why?
|
| Critical Illness | 1 | 2017 | 141 | 0.130 |
Why?
|
| Models, Theoretical | 1 | 2016 | 94 | 0.130 |
Why?
|
| Infant, Newborn | 1 | 2018 | 637 | 0.130 |
Why?
|
| Anemia | 1 | 2016 | 100 | 0.130 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 586 | 0.120 |
Why?
|
| Global Health | 1 | 2015 | 58 | 0.120 |
Why?
|
| Patient Admission | 2 | 2021 | 31 | 0.110 |
Why?
|
| Time Factors | 3 | 2020 | 1680 | 0.110 |
Why?
|
| Plasma | 1 | 2013 | 34 | 0.110 |
Why?
|
| Hypolipidemic Agents | 1 | 2013 | 23 | 0.110 |
Why?
|
| Hypertriglyceridemia | 1 | 2013 | 21 | 0.110 |
Why?
|
| Administration, Oral | 1 | 2013 | 139 | 0.110 |
Why?
|
| Angiography | 1 | 2012 | 44 | 0.100 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 555 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2020 | 1318 | 0.100 |
Why?
|
| Cohort Studies | 1 | 2017 | 2046 | 0.100 |
Why?
|
| Echocardiography | 1 | 2012 | 179 | 0.100 |
Why?
|
| Hospital Mortality | 2 | 2023 | 150 | 0.100 |
Why?
|
| Risk Assessment | 2 | 2021 | 718 | 0.090 |
Why?
|
| HIV Infections | 1 | 2017 | 888 | 0.090 |
Why?
|
| Biomarkers | 2 | 2020 | 734 | 0.090 |
Why?
|
| Atmospheric Pressure | 2 | 2019 | 12 | 0.080 |
Why?
|
| Patient Discharge | 2 | 2021 | 164 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 818 | 0.080 |
Why?
|
| United States | 1 | 2015 | 2376 | 0.080 |
Why?
|
| Administration, Intravenous | 1 | 2016 | 28 | 0.070 |
Why?
|
| Computed Tomography Angiography | 1 | 2016 | 35 | 0.070 |
Why?
|
| Forecasting | 1 | 2016 | 115 | 0.070 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 149 | 0.070 |
Why?
|
| Chicago | 2 | 2020 | 941 | 0.070 |
Why?
|
| Neurologic Examination | 1 | 2016 | 138 | 0.070 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 344 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2020 | 1899 | 0.060 |
Why?
|
| Rewarming | 1 | 2013 | 1 | 0.060 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2013 | 4 | 0.060 |
Why?
|
| Shivering | 1 | 2013 | 3 | 0.060 |
Why?
|
| Epidemiologic Methods | 1 | 2013 | 20 | 0.060 |
Why?
|
| Body Temperature | 1 | 2013 | 58 | 0.060 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 5197 | 0.060 |
Why?
|
| Hypertension | 2 | 2018 | 288 | 0.060 |
Why?
|
| Survivors | 1 | 2013 | 61 | 0.060 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2021 | 35 | 0.050 |
Why?
|
| Leukocyte Count | 1 | 2021 | 93 | 0.050 |
Why?
|
| Intensive Care Units | 1 | 2023 | 328 | 0.050 |
Why?
|
| Adolescent | 1 | 2016 | 2403 | 0.040 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 117 | 0.040 |
Why?
|
| Illinois | 1 | 2020 | 267 | 0.040 |
Why?
|
| Comorbidity | 1 | 2020 | 508 | 0.040 |
Why?
|
| Temperature | 1 | 2018 | 75 | 0.040 |
Why?
|
| Disability Evaluation | 1 | 2021 | 333 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2020 | 298 | 0.040 |
Why?
|
| Geriatric Assessment | 1 | 2020 | 238 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 274 | 0.040 |
Why?
|
| Hospitalization | 1 | 2020 | 336 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1507 | 0.030 |
Why?
|